Clinical effect of intravenous immunoglobulin on chronic idiopathic thrombocytopenic purpura
- 12 Downloads
High dose immunoglobulin infusions showed a marked effect on platelet counts in eight out of nine chronic ITP patients and in one SLE patient. In the comparison of different IgG-preparations, the pepsin treated IgG F (ab′)2 showed no platelet elevation while the sulfonated did. The elevated platelet count could not be maintained after discontinuation of IgG infusions, but in six out of ten patients the platelet level remained above the pretreatment values. This new treatment seems to be safe and effective in adulthood ITP.
Key wordsIdiopathic thrombocytopenic purpura in adulthood Intravenous immunoglobulin
Unable to display preview. Download preview PDF.
- 12.Shulman NR, Marder VI, Weinrach RS (1965) Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura: Physiologic, serologic and isotopic studies. Ann NY Acid Sci 124: 499–542Google Scholar
- 13.Karpatkin S, Siskin GW (1969) In vitro detection of platelet antibody in patients with idiopathic thrombocytopenic purpura and systemic lupus erythematosus. Blood 33: 759–812Google Scholar
- 17.Abe T, Matsuda J (1981) A study of new enzyme immunoassay for quantification of platelet bound IgG and its clinical significance. In: Nydegger UE (ed) Immunohemotherapy. A guide to immunoglobulin prophylaxis and therapy. Academic Press, New York, pp 409–418Google Scholar